CHEMOTHERAPY FOR RECURRENT AND METASTATIC CERVICAL-CANCER WITH STANDARD-DOSE METHOTREXATE-LEUCOVORIN, BLEOMYCIN AND CISPLATINUM

被引：0
作者：
VOGL, SE
SELTZER, V
CAMACHO, F
DAVIS, TE
机构：
[1] WISCONSIN CLIN CANC CTR,MADISON,WI
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[3] SUNY STONY BROOK,STONY BROOK,NY 11794
来源：
JOURNAL OF REPRODUCTIVE MEDICINE | 1986年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
[41]   Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer [J].
Tewari K.S. ;
Monk B.J. .
Current Oncology Reports, 2005, 7 (6) :419-434
[42]   Fixed-Dose vs Standard-Dose Capecitabine Maintains Survival, Decreases Toxicity in Metastatic Breast Cancer [J].
Rugo, Hope S. .
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) :353-354
[43]   Standard-dose vs fixed-dose capecitabine in patients with advanced gastrointestinal and metastatic breast cancer. [J].
Gvazava, Nanuli ;
Khan, Qamar J. ;
Clark, Lauren ;
Baranda, Joaquina Celebre ;
Sharma, Priyanka ;
Monson, Taylor ;
Phadnis, Milind A. ;
Bohnenkamp, Colleen ;
O'Dea, Anne ;
Elia, Manana ;
Nye, Lauren Elizabeth ;
Pluenneke, Robert E. ;
Mitchell, Laura ;
Al-Rajabi, Raed Moh'd Taiseer ;
Fesen, Mark Robert ;
LaFaver, Stephanie ;
Kasi, Anup .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL) :1091-1091
[44]   CISPLATIN, FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN FOR RECURRENT OR METASTATIC HEAD AND NECK-CANCER [J].
VOKES, EE ;
CHOI, KE ;
SCHILSKY, RL ;
MORAN, WJ ;
GUARNIERI, CM ;
WEICHSELBAUM, RR ;
PANJE, WR .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :618-626
[45]   Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study [J].
Nayan, Navin ;
Bhattacharyya, M. ;
Jagtap, Vikas K. ;
Kalita, A. K. ;
Sunku, R. ;
Roy, P. S. .
SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) :27-30
[46]   DOSE INTENSITY OF CHEMOTHERAPY IN RECURRENT AND OR METASTATIC HEAD AND NECK-CANCER [J].
CHOKSI, AJ ;
DIMERY, IW ;
GLISSON, BS ;
ATKINSON, EN ;
MCCARTHY, K ;
PAREDES, J ;
KRAMER, AM ;
HONG, WK .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 :209-209
[47]   CHEMOTHERAPY FOR ADVANCED CERVICAL-CANCER WITH BLEOMYCIN, VINCRISTINE, MITOMYCIN-C, AND CIS-DIAMMINEDICHLOROPLATINUM(II) (BOMP) [J].
VOGL, SE ;
MOUKHTAR, M ;
CALANOG, A ;
GREENWALD, EH ;
KAPLAN, BH .
CANCER TREATMENT REPORTS, 1980, 64 (8-9) :1005-1007
[48]   CHEMOTHERAPY OF RECURRENT ADVANCED CERVICAL-CANCER - RESULTS OF THE YALE-UNIVERSITY PBM PFU PROTOCOL [J].
CHAMBERS, SK ;
LAMB, L ;
KOHORN, EI ;
SCHWARTZ, PE ;
CHAMBERS, JT .
GYNECOLOGIC ONCOLOGY, 1994, 53 (02) :161-169
[49]   Bevacizumab plus chemotherapy versus combination chemotherapy only in metastatic, recurrent, and persistent cervical cancer [J].
Choi, H. ;
Kim, B. G. ;
Lee, Y. Y. .
GYNECOLOGIC ONCOLOGY, 2019, 154 :275-275
[50]   Oxaliplatin,Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients [J].
Bing Han Ruihua Xu Yanxia Shi Huiyan Luo Xiaojuan Xiang Yuhong Li Li Zhang Tongyu Lin Youjian HeDepartment of Medical OncologySun Yat sen University Cancer CenterGuangzhou China .
Chinese Journal of Clinical Oncology, 2007, (06) :397-400
12345